Skip to main content

Day: October 11, 2021

Atlantic Union Bankshares Corporation To Release Third Quarter 2021 Results

RICHMOND, Va., Oct. 11, 2021 (GLOBE NEWSWIRE) — Atlantic Union Bankshares Corporation (the “Company”) today announced that it will release third quarter 2021 results before the market opens on Monday, October 25, 2021. Following the release, the Company will host a conference call and webcast for analysts at 9:00 a.m. Eastern Time on Monday, October 25, 2021. Management will conduct a conference call and listen-only webcast with accompanying slides, which can be found at: https://edge.media-server.com/mmc/p/zze37wck To participate in the call, please use one of the following telephone numbers.Participant Toll-Free Dial-In Number: (866) 220-4170Participant International Dial-In Number: (864) 663-5235The conference ID is: 1236699 A replay of the webcast, and the accompanying slides, will be available on the Company’s website...

Continue reading

aTyr Pharma to Participate in Piper Sandler Investor Lung Day

SAN DIEGO, Oct. 11, 2021 (GLOBE NEWSWIRE) — aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, today announced that Sanjay S. Shukla, M.D., M.S., President and Chief Executive Officer, will participate in a fireside chat as part of the Piper Sandler Virtual Investor Day: Developing Therapeutics for Lung Indications on Friday, October 15, 2021, at 9:00am ET / 6:00am PT. The discussion will be moderated by Ted Tenthoff, Senior Research Analyst at Piper Sandler. Following the event, a replay of the fireside chat will be available on the Investor’s section of the company’s website at www.atyrpharma.com and will be available for at least 90 days. About aTyr aTyr is a biotherapeutics company engaged in the discovery and development...

Continue reading

Willis Towers Watson and Qontigo launch pioneering STOXX global index series that quantifies companies’ climate transition risk

Enables investors to address financial risk to company share prices caused by a climate transition by building balanced, mainstream, Paris-aligned portfolios Innovative, proprietary approach looks beyond simple strategies such as carbon exposure Major market innovation for CoP26 private finance agendaARLINGTON, Va., Oct. 11, 2021 (GLOBE NEWSWIRE) — Qontigo and Willis Towers Watson launched an innovative family of climate transition indices driven by a next generation methodology that directly quantifies the impact of a Paris-aligned climate transition on equity valuations. The STOXX Willis Towers Watson Climate Transition Indices (CTI) help investors, governments and companies to manage risk, capture opportunities in their portfolios, align with goals of the Paris agreement and work toward net-zero targets. The CTI enables...

Continue reading

DeFi Technologies Inc. Featured in Syndicated Broadcast Covering Expansion of Management Team to Support Growth in European and Global Markets

LOS ANGELES, Oct. 11, 2021 (GLOBE NEWSWIRE) — via InvestorWire — DeFi Technologies Inc. (NEO: DEFI) (GR: RMJ.F) (OTC: DEFTF), a digital asset investment firm bridging the gap between traditional capital markets and decentralized finance, today announces that it has been featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio press release covers DeFi Technologies’ recent announcement detailing the expansion of its management team. To hear the audio production, visit: https://www.nnw.fm/BI0rY To read the original press release, visit: https://nnw.fm/f4w0A Per the news release, Russell Starr, Executive Chairman of DeFi Technologies, will assume the role of CEO;...

Continue reading

CNS Pharmaceuticals Inc. Featured in Syndicated Broadcast Covering Dosing of First Patients in Its Berubicin Clinical Development Program for Glioblastoma Multiforme

LOS ANGELES, Oct. 11, 2021 (GLOBE NEWSWIRE) — via InvestorWire — CNS Pharmaceuticals Inc. (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announces that it has been featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio press release covers CNS Pharmaceuticals’ recent announcement of dosing of the first patients in its Berubicin clinical development program for the treatment of recurrent glioblastoma multiforme (GBM), one of the most aggressive types of brain cancer. To hear the audio production, visit: https://www.nnw.fm/imIah To...

Continue reading

SI-BONE, Inc. Announces UnitedHealthcare Adopts Exclusive iFuse Only Coverage for Minimally Invasive SI Joint Fusion

The transition to an exclusive triangular implant policy by UnitedHealthcare, the nation’s largest health insurer, is supported by over 100+ peer-reviewed publications, and comes as SI-BONE surpasses 60,000 iFuse procedures performed by more than 2,500 surgeons worldwide SANTA CLARA, Calif., Oct. 11, 2021 (GLOBE NEWSWIRE) — SI-BONE, Inc., (Nasdaq: SIBN) a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacro-pelvic anatomy, today announced that UnitedHealthcare has changed its minimally invasive SI joint fusion policy from covering all devices to exclusively covering SI-BONE’s triangular iFuse Implants, effective October 1, 2021. UnitedHealthcare has adopted InterQual Clinical Criteria for Sacroiliac Joint Interventions, updating its policies to cover minimally invasive SI joint...

Continue reading

Athenex Provides Update from FDA Type A Meeting Regarding Oral Paclitaxel + Encequidar in Metastatic Breast Cancer

BUFFALO, N.Y., Oct. 11, 2021 (GLOBE NEWSWIRE) — Athenex (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today announced that it recently held a Type A meeting with the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for oral paclitaxel and encequidar (Oral Paclitaxel) in metastatic breast cancer (mBC). The purpose of the meeting was to review with the FDA a proposed design for a new clinical trial intended to address the deficiencies raised in the Complete Response Letter received in February 2021 and discuss the potential regulatory path forward for Oral Paclitaxel in mBC in the U.S.    “We had an informative meeting with the FDA, which was an important step to...

Continue reading

APA Corporation Achieves Goal to Eliminate Routine Flaring Onshore US

HOUSTON, Oct. 11, 2021 (GLOBE NEWSWIRE) — APA Corporation (Nasdaq: APA) today announced its subsidiary, Apache Corporation, has ended routine flaring in its U.S. onshore operations, achieving one of its 2021 ESG goals three months ahead of schedule. “In early 2021, we set out to eliminate routine flaring in U.S. onshore operations as part of our broader efforts to continuously reduce our environmental footprint. We established an aggressive goal, and I am proud to announce we have achieved the goal ahead of schedule,” said John J. Christmann IV, APA’s CEO and president. “I’m grateful for our dedicated team, who has been working diligently to make this happen. We attained the goal through a concentrated effort, which included communicating clear objectives along with adding compression and optimizing facilities so more gas could...

Continue reading

Rosinbomb™and World-Renowned Industry Icon Tommy Chong Announce a Second Exclusive Product Collaboration

Following Up on Their Successful Initial Campaign Industy Leaders Team Up to Create Another Iconic Extraction Press Design Featuring Tommy’s Rare Art Etched on the Product and Signed by Tommy RENO, Nev., Oct. 11, 2021 (GLOBE NEWSWIRE) — ROSINBOMB (OTC:ROSN), industry leading developer and manufacturer of the highly acclaimed ROSINBOMB line of solventless extraction presses and Industry Icon Tommy Chong announced today that they have agreed to launch another exclusive and limited edition, custom Rosinbomb Rocket consumer extraction press. The Rosinbomb Rocket is widely acclaimed as the best personal, solventless rosin press in the world and has been featured in Forbes and Engadget. As part of this innovative initiative to merge creative design and function, Rosinbomb and its partner entertainment and industry and cultural icon Tommy...

Continue reading

B2Digital CEO Greg Bell Joins Jane King on Fox Business Tonight, October 11 at 10:30 PM PST

TAMPA, FL, Oct. 11, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – B2Digital Incorporated (the “Company” or “B2Digital”) (OTCMKTS:BTDG), the premier development league for mixed martial arts (“MMA”), is pleased to announce that FMW Media’s “New To The Street” business TV show will continue to feature B2Digital CEO Greg P. Bell. Interested viewers can catch the interview tonight, Monday, October 11th at 10:30 p.m. PST on Fox Business Network as Mr. Greg Bell talks with New to The Street T.V.’s host Jane King, about the Company’s “Premier Vertically Integrated” LIVE Sporting events as B2Digital continues to focus on growing a minor league division for the professional MMA (Mixed Martial Arts) and the continued corporate expansion of the One More Gym brand. FMW Media’s “New to The Street” TV brand is...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.